Noxafil (posaconazole delayed-release tablets [generic], oral suspension [generic], PowderMix for delayed-release oral suspension - Merck) — Cigna
Fungal Infection (Systemic) that is Susceptible to Posaconazole – Treatment
Initial criteria
- Systemic fungal infection confirmed or likely to be susceptible to posaconazole
Approval duration
3 months